79211-9
Fetal Chromosome X and Y aneuploidy risk [interpretation] in Plasma cell-free DNA Qualitative by Sequencing
Active
Term Description
The risk interpretation (e.g. increased risk) of chromosome X & Y aneuploidy present in fetal cell-free DNA from maternal plasma. This term was created for, but not limited in use to, QNatal Advanced, a non-invasive prenatal test which uses massively parallel sequencing to identify chromosome X & Y aneuploidy.
Source: Regenstrief LOINC
Part Description
LP150045-5 Sequencing
Sequencing is a method used to determine the sequence of individual genes, larger genetic regions (i.e. clusters of genes or operons), full chromosomes or entire genomes. Historically, most sequencing has been performed using the chain termination method developed by Frederick Sanger in 1977. PMID: 271968 Sequencing technologies have improved dramatically, making them cheaper, faster, and more accurate. Next-generation sequencing (NGS), also known as high-throughput sequencing, deep sequencing, and second-generation sequencing, is a type of technology that uses parallel sequencing of multiple small fragments of DNA to determine sequence. This "high-throughput" technology has increased the speed and amount of DNA sequenced at a significantly reduced cost. PMID: 18576944 Several NGS platforms (ie, sequencing instruments and associated reagents) have been developed. Third-generation sequencing is another methodology currently under development that uses parallel sequencing similar to NGS. In contrast to NGS, third-generation sequencing uses single DNA molecules rather than amplified DNA as a template. PMID: 20858600
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Fetal chromosome X & Y aneuploidy risk
- Property
- Imp
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- Ord
- Method
- Sequencing
Additional Names
- Short Name
- Fet X + Y aneup risk Plas.cfDNA Seq-Imp
- Display Name
- Chr X and Y aneuploidy risk Sequencing Ql (cfDNA) [Interp]
- Consumer Name Alpha Get Info
- Fetal Chromosome X and Y Aneuploidy Risk
Example Answer List: LL3710-2
Source: Quest Diagnostics Inc.Answer | Code | Score | Answer ID |
---|---|---|---|
No aneuploidy | LA24543-3 | ||
Increased risk | LA24544-1 |
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.54
- Last Updated
- Version 2.66
- Change Reason
- Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Observation
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Riesgo de aneuploidía X e Y: |
es-MX | Spanish (Mexico) | Riesgo de aneuploidía fetal de los cromosomas X e Y: |
fr-FR | French (France) | Risque d'aneuploïdie foetale chromosome X et Y: |
it-IT | Italian (Italy) | Cromosomi X & Y, aneuploidia, rischio: Synonyms: Aneuploidia dei cromosomi X e Y DNA libero circolante nel plasma Impressione/interpretazione di studio Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di aneuploidia dei cromosomi X e Y |
tr-TR | Turkish (Turkey) | Kromozom X ve Y anöploid riski: Synonyms: Dizi tayini Plazma hücresiz DNA |
zh-CN | Chinese (China) | 胎儿染色体 X 与 Y 非整倍体性风险: Synonyms: 依次型; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=79211-9
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright